Conference abstract · 30 May 2018
Conference abstractPublished 8 Jun 2018
AS-6 suppresses lipopolysaccharide–induced neuroinflammation in BV2 microglial cells via inhibition of NF-κB and MAPK pathway
SungKyunKwan University, South Korea
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
4-O-carboxymethylascochlorin (AS-6, MW 462.96) isolated from Ascochyta viciae has been known to promote cell cycle arrest and inhibit invasion of tumor cells. We have previously studied structurally similar compounds ascochlorin (ASC; MW 404.93) and ascofuranone (AF; MW 420.93) with regard to its anti-inflammatory activity. In this study, we have found that the production of nitric oxide (NO), a main regulator of inflammation, is suppressed by AS-6 on BV2 microglial cells, when induced by LPS. In addition, AS-6 attenuated the increase in cyclooxyenase-2 (COX-2) protein and mRNA levels in lipopolysaccharide (LPS)-activated BV2 microglial cells in a dose-dependent manner. Moreover, AS-6 inhibited the expression and release of pro-inflammatory cytokines of tumor necrosis factor-alpha (TNF-Ã?±), interleukin-6 (IL-6), and interleukin-1Ã?² (IL-1Ã?²) in BV2 microglial cells. At the intracellular level, AS-6 inhibited LPS-induced nuclear translocation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-Ã?ºB) in BV2 microglial cells. Therefore, we investigated whether AS-6 affects mitogen-activated protein kinase (MAPK) phosphorylation, a process known as the upstream signaling regulator. AS-6 dramatically reduced the expression level of the phosphorylated forms of ERK, JNK, and p38 in LPS-activated BV2 microglial cells. These results indicate that AS-6 is a promising suppressor of the vascular inflammatory responses and AS-6 suppresses the LPS-induced inflammatory response in BV2 microglial cells by suppression of NFÃ?ºB and MAPKs signaling. Accordingly, AS-6 is suggested as a beneficial agent for the treatment of diseases that are associated with inflammation.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 31 Mar 2022
Exercise Improves High Fat-Induced Cognitive Impairment by Inhibiting Hippocampal Neuroinflammation via the Suppression of TLR4/MyD88/NF-κB Signaling Pathway
Research article · 31 Dec 2017
Mesuaferrin-A: Bio Active Flavonoid Inhibits LPS Stimulated Inflammatory Response via Down-Regulation of NF-κB and MAPK Signaling Pathways in RAW 264.7 Cell Lines
Conference abstract · 13 Jun 2018
Neurotropin inhibits neuroinflmmation via suppressing NF-Ã?ºB and MAPKs signaling pathways in lipopolysaccharide-stimulated BV2 cells
Research article · 21 Dec 2021
LGK974 Potentiates the Lethality of TRAIL in Hepatocellular Carcinoma Cells by Inducing Apoptosis via Suppressing NF-κB Signaling Pathway
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jun Young Park”
- BylineArticles whose byline prints “Sun-Hyung Ha”
- BylineArticles whose byline prints “Fukushi Abekura”
- BylineArticles whose byline prints “Hak Seong Lim”
- BylineArticles whose byline prints “Cheorl-Ho Kim”

